Development of a framework on the incorporation of real-world evidence (RWE) into cancer drug funding decisions in Canada: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration

Development of a framework on the incorporation of real-world evidence (RWE) into cancer drug funding decisions in Canada: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration

Objective The Canadian Real-world Evidence for Value in Cancer (CanREValue) Collaboration was established in response to growing interest in using real-world evidence (RWE) to support health technology assessment (HTA). CanREValue has developed a framework to generate and use RWE to inform cancer dr...

Full description

Saved in:
Bibliographic Details
Main Authors: Stuart Peacock, Avram Denburg, Petros Pechlivanoglou, Wanrudee Isaranuwatchai, Claire de Oliveira, Yvonne Bombard, Scott Gavura, Jeffrey Hoch, Rebecca E Mercer, Wei Fang Dai, Jaclyn Beca, Mina Tadrous, Carole Chambers, Maureen Trudeau, Craig C Earle, Kelvin Kar-Wing Chan, Winson Y Cheung, Pam Takhar, William K Evans, Caroline Muñoz, Erica Craig, Marc Geirnaert, Tarry Ahuja, Riaz Alvi
Format: Article
Language:English
Published: BMJ Publishing Group 2025-05-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/15/5/e096286.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://bmjopen.bmj.com/content/15/5/e096286.full

Similar Items